Beauty Health (NASDAQ:SKIN) Price Target Lowered to $1.50 at TD Cowen

Beauty Health (NASDAQ:SKIN) had its target price reduced by TD Cowen from $1.65 to $1.50 in a research note released on Monday morning, Marketbeat Ratings reports. They currently have a hold rating on the stock.

Several other research firms also recently commented on SKIN. Canaccord Genuity Group reissued a “hold” rating and set a $1.50 price target on shares of Beauty Health in a research note on Friday. Zacks Research lowered shares of Beauty Health from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 21st. Jefferies Financial Group reiterated a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a research report on Wednesday, January 14th. Finally, Benchmark reissued a “hold” rating on shares of Beauty Health in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $2.42.

Beauty Health Price Performance

Shares of Beauty Health stock opened at $1.20 on Monday. The firm has a market capitalization of $152.36 million, a PE ratio of -5.97 and a beta of 1.20. The company has a current ratio of 1.66, a quick ratio of 1.40 and a debt-to-equity ratio of 3.94. Beauty Health has a 12 month low of $0.78 and a 12 month high of $2.69. The business’s 50-day moving average price is $1.27 and its 200-day moving average price is $1.50.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $82.37 million during the quarter, compared to the consensus estimate of $78.07 million. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%. Sell-side analysts forecast that Beauty Health will post -0.25 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of SKIN. Public Employees Retirement System of Ohio bought a new position in Beauty Health during the 3rd quarter valued at approximately $26,000. Atom Investors LP bought a new position in shares of Beauty Health during the fourth quarter valued at approximately $29,000. CWM LLC raised its holdings in shares of Beauty Health by 232.8% during the fourth quarter. CWM LLC now owns 22,018 shares of the company’s stock valued at $31,000 after acquiring an additional 15,402 shares in the last quarter. Franklin Resources Inc. purchased a new stake in shares of Beauty Health in the 3rd quarter worth about $31,000. Finally, Ieq Capital LLC bought a new stake in shares of Beauty Health during the 4th quarter valued at about $33,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.